Sisonke: reaching several goals together
- PMID: 35305727
- PMCID: PMC8930005
- DOI: 10.1016/S0140-6736(22)00482-2
Sisonke: reaching several goals together
Conflict of interest statement
TF volunteered to participate in the Sisonke trials and WP volunteered to participate in the ENSEMBLE trial. TF as Vice-Dean of Clinical Services and Social Impact of the Faculty of Medicine and Health Sciences of the University of Stellenbosch, is responsible for the partnership between the health authority and the faculty in terms of teaching and clinical training. Additionally, she was responsible for the organisational component of vaccine roll-out in the faculty. WP is a member of the South African Ministerial Advisory Committee on COVID-19 vaccines.
Comment on
-
Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study.Lancet. 2022 Mar 19;399(10330):1141-1153. doi: 10.1016/S0140-6736(22)00007-1. Lancet. 2022. PMID: 35305740 Free PMC article.
References
-
- Tegally H, Wilkinson E, Giovanetti M, et al. Detection of a SARS-CoV-2 variant of concern in South Africa. Nature. 2021;592:438–443. - PubMed
-
- Venter WDF, Madhi SA, Nel J, Mendelson M, Van den Heever A, Moshabela M. South Africa should be using all the COVID-19 vaccines available to it—urgently. S Afr Med J. 2021;111:390–392. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
